in medical practice
procedures and consultations during her medical career
Diagnoses and treats children with various acute and chronic kidney disorders, kidney diseases and pathologies caused by chronic and autoimmune diseases or other chronic conditions.
As part of her continuous professional development she attends courses and conferences. She has co-published several publications and conference papers in her field.
Viktorija Lukošienė is a study coordinator of several clinical research projects in nephrology.
2001-2008 – medical doctor, integrated medicine studies, Faculty of Medicine, Vilnius University
2009-2014 – paediatrician and paediatric nephrologist, Paediatrics and Paediatric Nephrology Residency programme, Faculty of Medicine, Vilnius University
2016-present – paediatric nephrologist, Medical Diagnostic and Treatment Centre
2014-2016 –paediatric nephrologist, Antakalnio Polyclinic
2014-present– paediatrician, Paediatric Allergology Department, Antakalnio branch, Vilnius City Clinical Hospital
2013-2016 – paediatrician, Jūsų namuose paediatric polyclinic
2013-2013 – junior researcher, Clinic of Children’s Diseases, Faculty of Medicine, Vilnius University
Paediatric nephrologist licence
2013 – Peritoneal dialysis training, 3-day seminar, Kaunas
2010 – Emergency care for children, 3-day training, Vilnius
2010 – Good clinical practice course for study researchers, Johnson & Johnson, Vilnius
2007 – Neonatal listeriosis, final thesis of the medicine study programme
2007 – Neonatal listeriosis, presentation at the international neonatology science and practice conference ‘Neonatal infection’
2014 – Cyclosporine therapy outcomes for steroid resistant nephrotic syndrome in children, presentation at the annual scientific conference of the Lithuanian Paediatric Society ‘Children’s health in Lithuania 2014’
Co-author of other articles and conference papers.
2009-present – member of the Lithuanian Society of Paediatric Nephrology
Study coordinator, 4C study (Study of cardiovascular disease morbidity in children with chronic kidney disease), study began on 29 April 2009.
Study coordinator, DORI-PED-3002 phase 3 study (Prospective randomised double-blind multicentre study to determine the safety and tolerance of doripenem in comparison to cefepime in children under stationary treatment due to complicated urinary infection), study began on 9 February 2012.
Music, dance, sport.